179P Efficacy and safety of extended-interval dosing strategy of immune checkpoint inhibitors during the COVID-19 outbreak: Experience from a single center

Autor:	Hervé Lena, C. Pierre, S. Luzi, Y. Le Guen, T. Goter, C. Agar, Charles Ricordel
Rok vydání:	2021
Předmět:	Pulmonary and Respiratory Medicine Oncology medicine.medical_specialty Advanced Nsclc Coronavirus disease 2019 (COVID-19) business.industry Immune checkpoint inhibitors Outbreak Single Center Extended interval dosing Internal medicine Medicine business
Zdroj:	Journal of Thoracic Oncology
ISSN:	1556-0864
DOI:	10.1016/s1556-0864(21)02021-9
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9616ea093f297553cf25847df6e7733b https://doi.org/10.1016/s1556-0864(21)02021-9 Zobrazit plný text záznamu